-
Bayer AG and Meituan Deepen Partnership to Transform Skin Health Market in China
•
Bayer AG (ETR: BAYN), a leading German multinational pharmaceutical and life sciences company, has expanded its partnership with Meituan’s medical and healthcare business unit, a major player in China’s delivery services. The new collaboration will concentrate on the skin health sector, with a focus on online retail, digital marketing, and…
-
JD Healthcare and Genrix Bio Join Forces to Revolutionize Patient Care and Pharmacy Services
•
JD Healthcare, a subsidiary of China’s e-commerce juggernaut JD.com (NASDAQ: JD), has formed a strategic partnership with Chongqing Genrix Bio Pharmaceutical Co., Ltd. This alliance combines Genrix Bio’s prowess in drug research and development with JD Healthcare’s extensive resource and ecological advantages in medical treatment, medication, health management, and insurance.…
-
ClouDr Receives NMPA Green Light for ClouDT-01, a Groundbreaking Digital Diabetes Treatment
•
Hangzhou Kang Ming Information Technology Co., Ltd, trading under the banner of “ClouDr” on the Hong Kong stock exchange (HKG: 9955), has announced that it has secured marketing approval from the National Medical Products Administration (NMPA) for its innovative digital medicine product, ClouDT-01, designed for the treatment of diabetes. Leveraging…
-
E-Health Now Secures USD 13.8 Million in Series C Financing to Expand AI Medical Services
•
E-Health Now, a China-based one-stop artificial intelligence (AI)-powered medical health service platform, has reportedly secured nearly RMB 100 million (USD 13.8 million) in a Series C financing round. The funding round attracted notable investors such as Ameba Capital, Ventech China, and Borchid Capital. The capital raised is intended to fuel…
-
Jiangsu Yuyue Medical Teams Up with China Unicom for Digital Healthcare Innovation
•
Shanghai-based Jiangsu Yuyue Medical Equipment Inc. (SHE: 002223) has announced a strategic partnership with China Unicom, aiming to enhance digitalization in enterprise management, product digitization, and global technological empowerment. China Unicom will utilize its network, cloud, communication technology, and AI algorithms to advance the intelligence and digital upgrade of Yuyue’s…
-
Baidu Health Partners with Souyao to Boost Offline Pharmacy Services in China
•
Baidu Health has entered into a partnership with Beijing-based pharmaceutical business service provider Souyao. The collaboration will capitalize on Baidu’s resource advantages in areas such as search engines, map navigation, health services, artificial intelligence (AI), and e-commerce to offer comprehensive technical and operational services for brick-and-mortar pharmacies. The goal is…
-
SciClone Pharmaceuticals Teams Up with SPH Health and Hi Dr to Launch Internet Hospital in China
•
SciClone Pharmaceuticals Inc., (HKG: 6600), a prominent player in China’s pharmaceutical industry, has joined forces with SPH Health Commerce Co., Ltd and Hi Dr to establish an Internet hospital. The tripartite partnership aims to leverage digital healthcare solutions, although no financial details of the agreement have been disclosed. SciClone, known…
-
China’s State Council Unveils 26 Initiatives to Enhance Grey-hair Economy
•
The State Council has unveiled the “Opinions on Developing the Grey-hair Economy to Boost Wellbeing of the Elderly,” outlining 26 initiatives aimed at enhancing the quality of life for the aging population through improved livelihood, product supply, industrial growth, and security measures. Key recommendations include the optimization of elderly health…
-
ClouDr Partners with Yangtze River Pharmaceutical to Digitize Chronic Disease Marketing
•
Hangzhou Kang Ming Information Technology Co., Ltd, trading as “ClouDr” (HKG: 9955), has entered into a partnership with fellow Chinese company Yangtze River Pharmaceutical (Group) Co., Ltd. The collaboration will concentrate on providing digitalized marketing services within specific chronic disease sectors, with both parties looking to expand and deepen their…
-
AstraZeneca Launches Evinova to Enhance Global Clinical Development with Digital Health Solutions
•
UK-based AstraZeneca (AZ; NASDAQ: AZN) has launched Evinova, a digital health solutions provider, with the aim of supporting global clinical development. Evinova offers AI-enabled technologies and services to clinical trial (CT) sponsors, clinical research organizations (CROs), CT site care teams, and patients. The new business unit will initially focus on…
